ICC Labs Stock Forecast, Price & News

-0.10 (-5.81 %)
(As of 11/26/2018)
Today's Range
50-Day Range
52-Week Range
Volume646,156 shs
Average Volume799,310 shs
Market CapitalizationC$223.63 million
P/E Ratio95.29
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive ICC News and Ratings via Email

Sign-up to receive the latest news and ratings for ICC Labs and its competitors with MarketBeat's FREE daily newsletter.

About ICC Labs

ICC Labs Inc., through its subsidiaries, produces and sells cannabis in Uruguay. It offers recreational cannabis, medicinal cannabis, cannabinoid extracts, and by-products for medicinal, recreational, and industrial use, as well as industrial hemp. The company is headquartered in Vancouver, Canada.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

0.48 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

ICC Labs (CVE:ICC) Frequently Asked Questions

What stocks does MarketBeat like better than ICC Labs?

Wall Street analysts have given ICC Labs a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but ICC Labs wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How has ICC Labs' stock been impacted by Coronavirus (COVID-19)?

ICC Labs' stock was trading at C$1.62 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, ICC stock has increased by 0.0% and is now trading at C$1.62.
View which stocks have been most impacted by COVID-19

Who are ICC Labs' key executives?

ICC Labs' management team includes the following people:
  • Mr. Alejandro Antalich, Chief Exec. Officer
  • Mr. Oscar Alejandro Leon, Chief Financial Officer
  • Mr. Diego Taranto, Sr. Financial Controller

Who are some of ICC Labs' key competitors?

What other stocks do shareholders of ICC Labs own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ICC Labs investors own include Aphria (APHA), Canopy Growth (WEED), Aurora Cannabis (ACB), Aurora Cannabis (ACBFF), Emblem (EMC), Medical Marijuana (MJNA), WeedMD (WMD), 22nd Century Group (XXII), Cannabix Technologies (BLO) and Auxly Cannabis Group (CBWTF).

What is ICC Labs' stock symbol?

ICC Labs trades on the Canadian Venture Exchange (CVE) under the ticker symbol "ICC."

How do I buy shares of ICC Labs?

Shares of ICC and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is ICC Labs' stock price today?

One share of ICC stock can currently be purchased for approximately C$1.62.

How much money does ICC Labs make?

ICC Labs has a market capitalization of C$223.63 million and generates C$533,684.00 in revenue each year.

What is ICC Labs' official website?

The official website for ICC Labs is

Where are ICC Labs' headquarters?

ICC Labs is headquartered at 595 Burrard Street Suite 700 Stn Bentall Centre PO Box 49290, VANCOUVER, BC V7X 1S8, Canada.

How can I contact ICC Labs?

ICC Labs' mailing address is 595 Burrard Street Suite 700 Stn Bentall Centre PO Box 49290, VANCOUVER, BC V7X 1S8, Canada. The company can be reached via phone at +1-604-6892646.

This page was last updated on 6/25/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.